• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CT 影像组学列线图预测肺腺癌 T790M 突变的应用价值。

Application value of CT radiomic nomogram in predicting T790M mutation of lung adenocarcinoma.

机构信息

Department of Radiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350005, China.

Department of Radiology, Fujian Provincial Cancer Hospital, Fuzhou, Fujian, 350014, China.

出版信息

BMC Pulm Med. 2023 Sep 11;23(1):339. doi: 10.1186/s12890-023-02609-y.

DOI:10.1186/s12890-023-02609-y
PMID:37697337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10494384/
Abstract

BACKGROUND

The purpose of this study was to develop a radiomic nomogram to predict T790M mutation of lung adenocarcinoma base on non-enhanced CT lung images.

METHODS

This retrospective study reviewed demographic data and lung CT images of 215 lung adenocarcinoma patients with T790M gene test results. 215 patients (including 52 positive) were divided into a training set (n = 150, 36 positive) and an independent test set (n = 65, 16 positive). Multivariate logistic regression was used to select demographic data and CT semantic features to build clinical model. We extracted quantitative features from the volume of interest (VOI) of the lesion, and developed the radiomic model with different feature selection algorithms and classifiers. The models were trained by a 5-fold cross validation strategy on the training set and assessed on the test set. ROC was used to estimate the performance of the clinical model, radiomic model, and merged nomogram.

RESULTS

Three demographic features (gender, smoking, emphysema) and ten radiomic features (Kruskal-Wallis as selection algorithm, LASSO Logistic Regression as classifier) were determined to build the models. The AUC of the clinical model, radiomic model, and nomogram in the test set were 0.742(95%CI, 0.619-0.843), 0.810(95%CI, 0.696-0.907), 0.841(95%CI, 0.743-0.938), respectively. The predictive efficacy of the nomogram was better than the clinical model (p = 0.042). The nomogram predicted T790M mutation with cutoff value was 0.69 and the score was above 130.

CONCLUSION

The nomogram developed in this study is a non-invasive, convenient, and economical method for predicting T790M mutation of lung adenocarcinoma, which has a good prospect for clinical application.

摘要

背景

本研究旨在基于非增强 CT 肺图像开发一种预测肺腺癌 T790M 突变的放射组学列线图。

方法

这项回顾性研究回顾了 215 例 T790M 基因检测结果为阳性的肺腺癌患者的人口统计学数据和肺 CT 图像。215 例患者(包括 52 例阳性)分为训练集(n=150,36 例阳性)和独立测试集(n=65,16 例阳性)。采用多变量逻辑回归选择人口统计学数据和 CT 语义特征来构建临床模型。我们从病变的感兴趣体积(VOI)中提取定量特征,并使用不同的特征选择算法和分类器开发放射组学模型。通过在训练集上进行 5 折交叉验证策略来训练模型,并在测试集上进行评估。ROC 用于估计临床模型、放射组学模型和合并列线图的性能。

结果

确定了三个人口统计学特征(性别、吸烟、肺气肿)和十个放射组学特征(Kruskal-Wallis 作为选择算法,LASSO 逻辑回归作为分类器)来构建模型。测试集中临床模型、放射组学模型和列线图的 AUC 分别为 0.742(95%CI,0.619-0.843)、0.810(95%CI,0.696-0.907)和 0.841(95%CI,0.743-0.938)。列线图的预测效能优于临床模型(p=0.042)。列线图预测 T790M 突变的截断值为 0.69,评分高于 130。

结论

本研究开发的列线图是一种非侵入性、方便、经济的预测肺腺癌 T790M 突变的方法,具有良好的临床应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/b2726d70a086/12890_2023_2609_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/f99a5b5d9944/12890_2023_2609_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/5031cd452460/12890_2023_2609_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/eb05350f9ed9/12890_2023_2609_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/310172f19d85/12890_2023_2609_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/6a6ab46810b6/12890_2023_2609_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/b2726d70a086/12890_2023_2609_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/f99a5b5d9944/12890_2023_2609_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/5031cd452460/12890_2023_2609_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/eb05350f9ed9/12890_2023_2609_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/310172f19d85/12890_2023_2609_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/6a6ab46810b6/12890_2023_2609_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/10494384/b2726d70a086/12890_2023_2609_Fig6_HTML.jpg

相似文献

1
Application value of CT radiomic nomogram in predicting T790M mutation of lung adenocarcinoma.CT 影像组学列线图预测肺腺癌 T790M 突变的应用价值。
BMC Pulm Med. 2023 Sep 11;23(1):339. doi: 10.1186/s12890-023-02609-y.
2
A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.一种用于预测周围型肺腺癌表皮生长因子受体突变的新型放射组学列线图。
Phys Med Biol. 2020 Mar 6;65(5):055012. doi: 10.1088/1361-6560/ab6f98.
3
Can CT Radiomics Detect Acquired T790M Mutation and Predict Prognosis in Advanced Lung Adenocarcinoma With Progression After First- or Second-Generation EGFR TKIs?CT影像组学能否检测第一代或第二代EGFR-TKIs治疗后进展的晚期肺腺癌中获得性T790M突变并预测预后?
Front Oncol. 2022 Jul 6;12:904983. doi: 10.3389/fonc.2022.904983. eCollection 2022.
4
Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma.开发并外部验证基于 MRI 的列线图,以评估转移性肺腺癌患者的 EGFR 和 T790M 突变。
Eur Radiol. 2022 Oct;32(10):6739-6751. doi: 10.1007/s00330-022-08955-5. Epub 2022 Jun 22.
5
Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.基于肿瘤内、肿瘤旁和淋巴结放射组学特征的综合列线图预测 cT1N0M0 肺腺癌淋巴结转移
Sci Rep. 2021 May 24;11(1):10829. doi: 10.1038/s41598-021-90367-4.
6
A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma.基于 PET/CT 数据和列线图的临床实用放射组学-临床联合模型预测肺腺癌中 EGFR 突变。
Eur Radiol. 2021 Aug;31(8):6259-6268. doi: 10.1007/s00330-020-07676-x. Epub 2021 Feb 5.
7
A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma.联合放射组学特征、临床特征和血清肿瘤标志物预测肺腺癌微乳头/实性成分的可能性。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241249168. doi: 10.1177/17534666241249168.
8
Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.肺腺癌纯磨玻璃结节的影像组学分析:侵袭性预测。
Eur Radiol. 2020 Jul;30(7):3650-3659. doi: 10.1007/s00330-020-06776-y. Epub 2020 Mar 11.
9
A comparative study to evaluate CT-based semantic and radiomic features in preoperative diagnosis of invasive pulmonary adenocarcinomas manifesting as subsolid nodules.一项基于 CT 的语义和放射组学特征在术前诊断表现为亚实性结节的浸润性肺腺癌的对比研究。
Sci Rep. 2021 Jan 18;11(1):66. doi: 10.1038/s41598-020-79690-4.
10
The development and validation of a radiomic nomogram for the preoperative prediction of lung adenocarcinoma.一种用于术前预测肺腺癌的放射组学列线图的开发和验证。
BMC Cancer. 2020 Jun 8;20(1):533. doi: 10.1186/s12885-020-07017-7.

引用本文的文献

1
Prediction of oncogene mutation status in non-small cell lung cancer: a systematic review and meta-analysis with a special focus on artificial intelligence-based methods.非小细胞肺癌中癌基因突变状态的预测:一项系统综述和荟萃分析,特别关注基于人工智能的方法
Eur Radiol. 2025 Sep 8. doi: 10.1007/s00330-025-11962-x.
2
The predictive value of the change of the number of pixels under different CT value intervals in the CT-occult central lung squamous cell carcinoma and squamous epithelial precancerous lesions.不同 CT 值区间内像素数变化对 CT 隐匿性中心型肺鳞癌及鳞状上皮癌前病变的预测价值。
BMC Pulm Med. 2023 Nov 3;23(1):426. doi: 10.1186/s12890-023-02732-w.

本文引用的文献

1
Predicting Tumor Mutation Burden and Mutation Using Clinical and Radiomic Features in Patients with Malignant Pulmonary Nodules.利用恶性肺结节患者的临床和影像组学特征预测肿瘤突变负荷和突变情况
J Pers Med. 2022 Dec 22;13(1):16. doi: 10.3390/jpm13010016.
2
Dynamic Assessment of Tissue and Plasma -Activating and T790M Mutations with Droplet Digital PCR Assays for Monitoring Response and Resistance in Non-Small Cell Lung Cancers Treated with EGFR-TKIs.采用液滴数字 PCR 分析检测组织和血浆中激活和 T790M 突变,动态评估非小细胞肺癌患者接受 EGFR-TKIs 治疗的反应和耐药情况。
Int J Mol Sci. 2022 Sep 26;23(19):11353. doi: 10.3390/ijms231911353.
3
Can CT Radiomics Detect Acquired T790M Mutation and Predict Prognosis in Advanced Lung Adenocarcinoma With Progression After First- or Second-Generation EGFR TKIs?
CT影像组学能否检测第一代或第二代EGFR-TKIs治疗后进展的晚期肺腺癌中获得性T790M突变并预测预后?
Front Oncol. 2022 Jul 6;12:904983. doi: 10.3389/fonc.2022.904983. eCollection 2022.
4
Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With -T790M Mutation Receiving Third-Generation EGFR-TKI Osimertinib Treatment.基于机器学习的CT影像组学分析在接受第三代EGFR-TKI奥希替尼治疗的伴有T790M突变的转移性非小细胞肺癌患者预后预测中的应用
Front Oncol. 2021 Sep 29;11:719919. doi: 10.3389/fonc.2021.719919. eCollection 2021.
5
Different Clinicopathologic and Computed Tomography Imaging Characteristics of Primary and Acquired Mutations in Patients with Non-Small-Cell Lung Cancer.非小细胞肺癌患者原发性和获得性突变的不同临床病理及计算机断层扫描成像特征
Cancer Manag Res. 2021 Aug 13;13:6389-6401. doi: 10.2147/CMAR.S323972. eCollection 2021.
6
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors.将非小细胞肺癌的放射组学表型与液体活检数据相结合,可能提高对表皮生长因子受体抑制剂反应的预测。
Sci Rep. 2021 May 11;11(1):9984. doi: 10.1038/s41598-021-88239-y.
7
Epidemiology of lung cancer.肺癌流行病学
Contemp Oncol (Pozn). 2021;25(1):45-52. doi: 10.5114/wo.2021.103829. Epub 2021 Feb 23.
8
Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.开发和验证一种机器学习模型,以探索 IV 期 EGFR 突变阳性非小细胞肺癌患者对酪氨酸激酶抑制剂的反应。
JAMA Netw Open. 2020 Dec 1;3(12):e2030442. doi: 10.1001/jamanetworkopen.2020.30442.
9
FeAture Explorer (FAE): A tool for developing and comparing radiomics models.特征探索器(FAE):一种用于开发和比较放射组学模型的工具。
PLoS One. 2020 Aug 17;15(8):e0237587. doi: 10.1371/journal.pone.0237587. eCollection 2020.
10
The Effect of Advances in Lung-Cancer Treatment on Population Mortality.肺癌治疗进展对人群死亡率的影响。
N Engl J Med. 2020 Aug 13;383(7):640-649. doi: 10.1056/NEJMoa1916623.